Differential susceptibility of interneurons expressing neuropeptide Y or parvalbumin in the aged hippocampus to acute seizure activity

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Kuruba, Ramkumar ^a,d   Hattiangady, Bharathi ^a,b,d   Parihar, Vipan K ^a,d   Shuai, Bing ^a,b,d   Shetty, Ashok K ^a,b,c,d  

^a DURHAM VA MEDICAL CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; KAINIC ACID; NEUROPEPTIDE Y; PARVALBUMIN;

ACUTE DISEASE; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SURVIVAL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GABAERGIC SYSTEM; HIPPOCAMPUS; INTERNEURON; NONHUMAN; PROTEIN EXPRESSION; RAT; SEIZURE; TEMPORAL LOBE EPILEPSY; ANIMAL; CYTOLOGY; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

RATTUS;

AGING; ANIMALS; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; NEUROPEPTIDE Y; PARVALBUMINS; RATS; RATS, INBRED F344; SEIZURES;

EID: 80052432709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024493     Document Type: Article

References (63)

1. Engel J Jr, (2001) Mesial temporal lobe epilepsy: what have we learned? Neuroscientist 7: 340-352.
2. Faught E, (1999) Epidemiology and drug treatment of epilepsy in elderly people. Drugs Aging 15: 255-269.
3. Hauser WA, (1992) Seizure disorders: the changes with age. Epilepsia 33 (Suppl 4): S6-14.
4. Hauser WA, Annegers JF, Kurland LT, (1993) Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 34: 453-468.
5. Wallace H, Shorvon S, Tallis R, (1998) Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 352: 1970-1973.
6. Landfield PW, Pitler TA, Applegate MD, (1986) The effects of high Mg2+-to-Ca2+ ratios on frequency potentiation in hippocampal slices of young and aged rats. J Neurophysiol 56: 797-811.
7. Barnes CA, Rao G, McNaughton BL, (1987) Increased electrotonic coupling in aged rat hippocampus: a possible mechanism for cellular excitability changes. J Comp Neurol 259: 549-558.
8. Kerr DS, Campbell LW, Applegate MD, Brodish A, Landfield PW, (1991) Chronic stress-induced acceleration of electrophysiologic and morphometric biomarkers of hippocampal aging. J Neurosci 11: 1316-1324.
9. Bekenstein JW, Lothman EW, (1993) Dormancy of inhibitory interneurons in a model of temporal lobe epilepsy. Science 259: 97-100.
10. Barnes CA, (1994) Normal aging: regionally specific changes in hippocampal synaptic transmission. Trends Neurosci 17: 13-18.
11. Papatheodoropoulos C, Kostopoulos G, (1996) Age-related changes in excitability and recurrent inhibition in the rat CA1 hippocampal region. Eur J Neurosci 8: 510-520.
12. Freund TF, Buzsaki G, (1996) Interneurons of the hippocampus. Hippocampus 6: 347-470.
13. Franck JE, Kunkel DD, Baskin DG, Schwartzkroin PA, (1988) Inhibition in kainate-lesioned hyperexcitable hippocampi: physiologic, autoradiographic, and immunocytochemical observations. J Neurosci 8: 1991-2002.
14. Cornish SM, Wheal HV, (1989) Long-term loss of paired pulse inhibition in the kainic acid-lesioned hippocampus of the rat. Neuroscience 28: 563-571.
15. Buzsaki G, Geisler C, Henze DA, Wang XJ, (2004) Interneuron Diversity series: Circuit complexity and axon wiring economy of cortical interneurons. Trends Neurosci 27: 186-193.
16. Treiman DM, (2001) GABAergic mechanisms in epilepsy. Epilepsia 42 (Suppl 3): 8-12.
17. Shetty AK, Turner DA, (1998) Hippocampal interneurons expressing glutamic acid decarboxylase and calcium-binding proteins decrease with aging in Fischer 344 rats. J Comp Neurol 394: 252-269.
18. Cadacio CL, Milner TA, Gallagher M, Pierce JP, (2003) Hilar neuropeptide Y interneuron loss in the aged rat hippocampal formation. Exp Neurol 183: 147-158.
19. Vela J, Gutierrez A, Vitorica J, Ruano D, (2003) Rat hippocampal GABAergic molecular markers are differentially affected by ageing. J Neurochem 85: 368-377.
20. Shi L, Argenta AE, Winseck AK, Brunso-Bechtold JK, (2004) Stereological quantification of GAD-67-immunoreactive neurons and boutons in the hippocampus of middle-aged and old Fischer 344 x Brown Norway rats. J Comp Neurol 478: 282-291.
21. Stanley DP, Shetty AK, (2004) Aging in the rat hippocampus is associated with widespread reductions in the number of glutamate decarboxylase-67 positive interneurons but not interneuron degeneration. J Neurochem 89: 204-216.
22. Shetty AK, Hattiangady B, Rao MS, (2009) Vulnerability of hippocampal GABA-ergic interneurons to kainate-induced excitotoxic injury during old age. J Cell Mol Med 13: 2408-2423.
23. Luebke JI, Rosene DL, (2003) Aging alters dendritic morphology, input resistance, and inhibitory signaling in dentate granule cells of the rhesus monkey. J Comp Neurol 460: 573-584.
24. Potier B, Jouvenceau A, Epelbaum J, Dutar P, (2006) Age-related alterations of GABAergic input to CA1 pyramidal neurons and its control by nicotinic acetylcholine receptors in rat hippocampus. Neuroscience 142: 187-201.
25. Liang LP, Beaudoin ME, Fritz MJ, Fulton R, Patel M, (2007) Kainate-induced seizures, oxidative stress and neuronal loss in aging rats. Neuroscience 147: 1114-1118.
26. Patrylo PR, Williamson A, (2007) The effects of aging on dentate circuitry and function. Prog Brain Res 163: 679-696.
27. McCord MC, Lorenzana A, Bloom CS, Chancer ZO, Schauwecker PE, (2008) Effect of age on kainate-induced seizure severity and cell death. Neuroscience 154: 1143-1153.
28. Hattiangady B, Kuruba R, Shetty AK, (2011) Acute Seizures in Old Age Leads to a Greater Loss of CA1 Pyramidal Neurons, an Increased Propensity for Developing Chronic TLE and a Severe Cognitive Dysfunction. Aging Dis 2: 1-17.
29. LaRoche SM, Helmers SL, (2003) Epilepsy in the elderly. Neurologist 9: 241-249.
30. Leppik IE, Kelly KM, deToledo-Morrell L, Patrylo PR, DeLorenzo RJ, et al. (2006) Basic research in epilepsy and aging. Epilepsy Res 68 (Suppl 1): S21-37.
31. Howell OW, Doyle K, Goodman JH, Scharfman HE, Herzog H, et al. (2005) Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus. J Neurochem 93: 560-570.
32. Sperk G, Hamilton T, Colmers WF, (2007) Neuropeptide Y in the dentate gyrus. Prog Brain Res 163: 285-297.
33. Fu LY, van den Pol AN, (2007) GABA excitation in mouse hilar neuropeptide Y neurons. J Physiol 579: 445-464.
34. Klausberger T, Marton LF, O'Neill J, Huck JH, Dalezios Y, et al. (2005) Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci 25: 9782-9793.
35. Schwaller B, Tetko IV, Tandon P, Silveira DC, Vreugdenhil M, et al. (2004) Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures. Mol Cell Neurosci 25: 650-663.
36. Andrioli A, Alonso-Nanclares L, Arellano JI, DeFelipe J, (2007) Quantitative analysis of parvalbumin-immunoreactive cells in the human epileptic hippocampus. Neuroscience 149: 131-143.
37. Scharfman HE, Goodman JH, Sollas AL, Croll SD, (2002) Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol 174: 201-214.
38. Hattiangady B, Rao MS, Shetty GA, Shetty AK, (2005) Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and neuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus. Exp Neurol 195: 353-371.
39. Weiss JH, Koh J, Baimbridge KG, Choi DW, (1990) Cortical neurons containing somatostatin- or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro. Neurology 40: 1288-1292.
40. Darbin O, Naritoku D, Patrylo PR, (2004) Aging alters electroencephalographic and clinical manifestations of kainate-induced status epilepticus. Epilepsia 45: 1219-1227.
41. Milner TA, Veznedaroglu E, (1992) Ultrastructural localization of neuropeptide Y-like immunoreactivity in the rat hippocampal formation. Hippocampus 2: 107-125.
42. Colmers WF, Bleakman D, (1994) Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci 17: 373-379.
43. Redrobe JP, Dumont Y, St-Pierre JA, Quirion R, (1999) Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Res 848: 153-166.
44. Sperk G, (1994) Kainic acid seizures in the rat. Prog Neurobiol 42: 1-32.
45. Kharlamov EA, Kharlamov A, Kelly KM, (2007) Changes in neuropeptide Y protein expression following photothrombotic brain infarction and epileptogenesis. Brain Res 1127: 151-162.
46. Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD, (1997) Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci 17: 8927-8936.
47. Klapstein GJ, Colmers WF, (1997) Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J Neurophysiol 78: 1651-1661.
48. Patrylo PR, van den Pol AN, Spencer DD, Williamson A, (1999) NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J Neurophysiol 82: 478-483.
49. Vezzani A, Sperk G, Colmers WF, (1999) Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22: 25-30.
50. Rodrigo C, Zaben M, Lawrence T, Laskowski A, Howell OW, et al. (2010) NPY augments the proliferative effect of FGF2 and increases the expression of FGFR1 on nestin positive postnatal hippocampal precursor cells, via the Y1 receptor. J Neurochem 113: 615-627.
51. Celio MR, Heizmann CW, (1981) Calcium-binding protein parvalbumin as a neuronal marker. Nature 293: 300-302.
52. Kosaka T, Katsumaru H, Hama K, Wu JY, Heizmann CW, (1987) GABAergic neurons containing the Ca2+-binding protein parvalbumin in the rat hippocampus and dentate gyrus. Brain Res 419: 119-130.
53. Murray AJ, Sauer JF, Riedel G, McClure C, Ansel L, et al. (2011) Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory. Nat Neurosci 14: 297-299.
54. Korotkova T, Fuchs EC, Ponomarenko A, von Engelhardt J, Monyer H, (2010) NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 68: 557-569.
55. Gruber B, Greber S, Rupp E, Sperk G, (1994) Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus 4: 474-482.
56. Spreafico R, Tassi L, Colombo N, Bramerio M, Galli C, et al. (2000) Inhibitory circuits in human dysplastic tissue. Epilepsia 41 (Suppl 6): S168-173.
57. Andre V, Marescaux C, Nehlig A, Fritschy JM, (2001) Alterations of hippocampal GAbaergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus 11: 452-468.
58. Sundstrom LE, Brana C, Gatherer M, Mepham J, Rougier A, (2001) Somatostatin- and neuropeptide Y-synthesizing neurones in the fascia dentata of humans with temporal lobe epilepsy. Brain 124: 688-697.
59. Sloviter RS, (1987) Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 235: 73-76.
60. Doherty J, Dingledine R, (2001) Reduced excitatory drive onto interneurons in the dentate gyrus after status epilepticus. J Neurosci 21: 2048-2057.
61. Kobayashi M, Buckmaster PS, (2003) Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 23: 2440-2452.
62. Sloviter RS, Zappone CA, Harvey BD, Bumanglag AV, Bender RA, et al. (2003) "Dormant basket cell" hypothesis revisited: relative vulnerabilities of dentate gyrus mossy cells and inhibitory interneurons after hippocampal status epilepticus in the rat. J Comp Neurol 459: 44-76.
63. Ben-Ari Y, (2006) Seizures beget seizures: the quest for GABA as a key player. Crit Rev Neurobiol 18: 135-144.